"Arming the Killer: an Antibody Engineering Perspective for Solid Tumors"
At the conclusion of this activity, the participant will be able to:
1. Describe the dual specificity antibody targeting in solid cancers
2. Summarize innovative approaches to improve cancer immunotherapy
3. Discuss the rational protein engineering in ovarian and breast cancers